$CNSY

Cerenome, Inc.

Nasdaq · Healthcare · Surgical & Medical Instruments & Apparatus · Houston, TX

CNSY chart

What traders are saying about $CNSY

Latest posts

Cerenome, Inc. news

Cerenome, Inc. key financials

USD2025202420232022
Revenue$5.2M$5.8M$4.9M–
Net income-$22.4M-$13.0M-$13.3M-$20.3M
Diluted EPS$-0.29$-2.34$-4.24$-11.58
Total assets (year end)$16.3M$6.6M$11.4M$23.9M
Cash and equivalents (year end)$4.3M$76,000$8.6M$18.1M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

  • 8-K8-K
  • 8-K8-K
  • 10-Q10-Q
  • 8-K8-K
  • 8-K8-K
  • 8-K8-K
  • 8-K8-K
  • 10-Q10-Q
  • 8-K8-K
  • 8-K8-K
  • 8-K8-K
  • 8-K8-K

About Cerenome, Inc.

Ticker
CNSY (Nasdaq)
Industry
Surgical & Medical Instruments & Apparatus
Headquarters
Houston, TX
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
1095981
Former names
PLUS THERAPEUTICS, INC., CYTORI THERAPEUTICS, INC., MACROPORE INC

Frequently asked questions

What exchange is Cerenome, Inc. listed on?

Cerenome, Inc. trades on the Nasdaq under the ticker symbol CNSY.

What industry is Cerenome, Inc. in?

Cerenome, Inc. is classified by the SEC under "Surgical & Medical Instruments & Apparatus", part of the Healthcare sector on StockTweeting.

Where is Cerenome, Inc. headquartered?

Cerenome, Inc.'s business address on file with the SEC is in Houston, TX.

When does Cerenome, Inc.'s fiscal year end?

Cerenome, Inc.'s fiscal year ends on December 31.

How much revenue did Cerenome, Inc. report?

Cerenome, Inc. reported $5.2M in revenue for calendar year 2025, according to its SEC filings.